Local and Systemic Release of Cytokines, Nerve Growth Factor, Prostaglandin E2, and Substance P in Incisional Wounds and Serum Following Cesarean Delivery

Journal of Pain

Volumn 9, Issue 7, 2008, Pages 650-657

  Carvalho, Brendan ^a   Clark, David J ^b   Angst, Martin S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

analgesia; Cesarean; cytokines; nerve growth factor; prostaglandin E2; substance P; wound

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE GROWTH FACTOR; PROSTAGLANDIN E2; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD ANALYSIS; CESAREAN SECTION; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MEDIATOR RELEASE; NORMAL HUMAN; PAIN ASSESSMENT; SPINAL ANESTHESIA; SURGICAL WOUND; TIME;

BIOLOGICAL MARKERS; CESAREAN SECTION; CHEMOKINE CCL2; CYTOKINES; DINOPROSTONE; FEASIBILITY STUDIES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOASSAY; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MACROPHAGE INFLAMMATORY PROTEINS; NERVE GROWTH FACTOR; PREGNANCY; PROSPECTIVE STUDIES; SUBSTANCE P; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 45549109711     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2008.02.004     Document Type: Article

References (30)

1. Baker E.A., and Leaper D.J. Proteinases, their inhibitors, and cytokine profiles in acute wound fluid. Wound Repair Regen 8 (2000) 392-398
2. Baker E.A., El-Gaddal S., Williams L., and Leaper D.J. Profiles of inflammatory cytokines following colorectal surgery: Relationship with wound healing and outcome. Wound Repair Regen 14 (2006) 566-572
3. Beilin B., Shavit Y., Trabekin E., Mordashev B., Mayburd E., Zeidel A., and Bessler H. The effects of postoperative pain management on immune response to surgery. Anesth Analg 97 (2003) 822-827
4. Buvanendran A., Kroin J.S., Berger R.A., Hallab N.J., Saha C., Negrescu C., Moric M., Caicedo M.S., and Tuman K.J. Upregulation of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans. Anesthesiology 104 (2006) 403-410
5. Cahill C.M., and Coderre T.J. Attenuation of hyperalgesia in a rat model of neuropathic pain after intrathecal pre- or post-treatment with a neurokinin-1 antagonist. Pain 95 (2002) 277-285
6. Clark J.D., Qiao Y., Li X., Shi X., Angst M.S., and Yeomans D.C. Blockade of the complement C5a receptor reduces incisional allodynia, edema, and cytokine expression. Anesthesiology 104 (2006) 1274-1282
7. Clark J.D., Shi X., Li X., Qiao Y., Liang D., Angst M.S., and Yeomans D.C. Morphine reduces local cytokine expression and neutrophil infiltration after incision. Mol Pain 3 (2007) 28
8. Cunha F.Q., Poole S., Lorenzetti B.B., and Ferreira S.H. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 107 (1992) 660-664
9. Cunha F.Q., Poole S., Lorenzetti B.B., Veiga F.H., and Ferreira S.H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4. Br J Pharmacol 126 (1999) 45-50
10. Dalby P.L., Ramanathan S., Rudy T.E., Roy L., Amenta J.S., and Aber A. Plasma and saliva substance P levels: The effects of acute pain in pregnant and non-pregnant women. Pain 69 (1997) 263-267
11. Di Marco E., Marchisio P.C., Bondanza S., Franzi A.T., Cancedda R., and De Luca M. Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J Biol Chem 266 (1991) 21718-21722
12. Elshal M.F., and McCoy J.P. Multiplex bead array assays: Performance evaluation and comparison of sensitivity to ELISA. Methods 38 (2006) 317-323
13. Ferreira S.H., Lorenzetti B.B., Bristow A.F., and Poole S. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334 (1988) 698-700
14. Gordon D.B., Stevenson K.K., Griffie J., Muchka S., Rapp C., and Ford-Roberts K. Opioid equianalgesic calculations. J Palliat Med 2 (1999) 209-218
15. Gordon S.M., Brahim J.S., Rowan J., Kent A., and Dionne R.A. Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: Replicate clinical trials in a tissue injury model. Clin Pharmacol Ther 72 (2002) 175-183
16. Heijmans-Antonissen C., Wesseldijk F., Munnikes R.J., Huygen F.J., van der Meijden P., Hop W.C., Hooijkaas H., and Zijlstra F.J. Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1. Mediators Inflamm 2006 (2006) 28398
17. Henry J.L. Substance P and inflammatory pain: Potential of substance P antagonists as analgesics. Agents Actions Suppl 41 (1993) 75-87
18. Holzheimer R.G., and Steinmetz W. Local and systemic concentrations of pro- and anti-inflammatory cytokines in human wounds. Eur J Med Res 5 (2000) 347-355
19. Kidd B.L., Photiou A., and Inglis J.J. The role of inflammatory mediators on nociception and pain in arthritis. Novartis Found Symp 260 (2004) 122-133 discussion 133-138, 277-279
20. Kristiansson M., Soop M., Sundqvist K.G., Soop A., Suontaka A.M., and Blomback M. Local vs systemic immune and haemostatic response to hip arthroplasty. Eur J Anaesthesiol 15 (1998) 260-270
21. Lorenzetti B.B., Poole S., Veiga F.H., Cunha F.Q., and Ferreira S.H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-13. Eur Cytokine Netw 12 (2001) 260-267
22. Mahdy A.M., Galley H.F., Abdel-Wahed M.A., el-Korny K.F., Sheta S.A., and Webster N.R. Differential modulation of interleukin-6 and interleukin-10 by diclofenac in patients undergoing major surgery. Br J Anaesth 88 (2002) 797-802
23. Marchand F., Perretti M., and McMahon S.B. Role of the immune system in chronic pain. Nat Rev Neurosci 6 (2005) 521-532
24. Poole S., Cunha F.Q., Selkirk S., Lorenzetti B.B., and Ferreira S.H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. Br J Pharmacol 115 (1995) 684-688
25. Roszkowski M.T., Swift J.Q., and Hargreaves K.M. Effect of NSAID administration on tissue levels of immunoreactive prostaglandin E2, leukotriene B4, and (S)-flurbiprofen following extraction of impacted third molars. Pain 73 (1997) 339-345
26. Tokunaga A., Onda M., Fujita I., Okuda T., Mizutani T., Kiyama T., Matsukura N., and Hunt T.K. Sequential changes in the cell mediators of peritoneal and wound fluids after surgery. Surg Today 23 (1993) 841-844
27. Verri Jr. W.A., Cunha T.M., Parada C.A., Poole S., Cunha F.Q., and Ferreira S.H. Hypernociceptive role of cytokines and chemokines: Targets for analgesic drug development?. Pharmacol Ther 112 (2006) 116-138
28. Watkins L.R., and Maier S.F. Immune regulation of central nervous system functions: From sickness responses to pathological pain. J Intern Med 257 (2005) 139-155
29. Wu C., Boustany L., Liang H., and Brennan T.J. Nerve growth factor expression after plantar incision in the rat. Anesthesiology 107 (2007) 128-135
30. Wu C.T., Jao S.W., Borel C.O., Yeh C.C., Li C.Y., Lu C.H., and Wong C.S. The effect of epidural clonidine on perioperative cytokine response, postoperative pain, and bowel function in patients undergoing colorectal surgery. Anesth Analg 99 (2004) 502-509